Diffusion-weighted MRI at 3 T for the evaluation of prostate cancer

American Journal of Roentgenology

Volumn 194, Issue 6, 2010, Pages 1461-1469

  Kim, Chan Kyo ^a   Park, Byung Kwan ^a   Kim, Bohyun ^b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Mayo Clinic College of Medicine   (United States)

Author keywords

Apparent diffusion coefficient; Diffusion weighted imaging; High field MRI; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; CONTRAST MEDIUM;

BLEEDING; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FOLLOW UP; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATE TUMOR; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RECURRENT CANCER; REVIEW; SEMINAL VESICLE; SIGNAL NOISE RATIO; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT RESPONSE; BIOPSY; DISEASE COURSE; INSTRUMENTATION; MALE; METHODOLOGY; PATHOLOGY;

BIOPSY; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE PROGRESSION; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 77953253573     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.09.3654     Document Type: Review

References (58)

1. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR 2007; 188:1622-1635
2. Gibbs P, Pickles MD, Turnbull LW. Diffusion imaging of the prostate at 3.0 tesla. Invest Radiol 2006; 41:185-188 (Pubitemid 44406217)
3. Kim CK, Park BK, Lee HM, Kwon GY. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results. Invest Radiol 2007; 42:842-847
4. Miao H, Fukatsu H, Ishigaki T. Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging. Eur J Radiol 2007; 61:297-302 (Pubitemid 46096691)
5. Kim CK, Choi D, Park BK, Kwon GY, Lim HK. Diffusion-weighted MR imaging for the evaluation of seminal vesicle invasion in prostate cancer: initial results. J Magn Reson Imaging 2008; 28:963-969
6. Gibbs P, Pickles MD, Turnbull LW. Repeatability of echo-planar-based diffusion measurements of the human prostate at 3 T. Magn Reson Imaging 2007; 25:1423-1429 (Pubitemid 350122914)
7. Pickles MD, Gibbs P, Sreenivas M, Turnbull LW. Diffusion-weighted imaging of normal and malignant prostate tissue at 3.0T. J Magn Reson Imaging 2006; 23:130-134 (Pubitemid 43191065)
8. Kim CK, Park BK. Update of prostate magnetic resonance imaging at 3 T. J Comput Assist Tomogr 2008; 32:163-172 (Pubitemid 351489432)
9. Manenti G, Carlani M, Mancino S, et al. Diffusion tensor magnetic resonance imaging of prostate cancer. Invest Radiol 2007; 42:412-419 (Pubitemid 46788741)
10. Kim CK, Park BK, Lee HM. Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI. J Magn Reson Imaging 2009; 29:391-397
11. Kim CK, Park BK, Lee HM, Kim SS, Kim E. MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer. AJR 2008; 190:1180-1186 (Pubitemid 351684917)
12. Kim CK, Park W, Park BK. Assessment of response to radiation therapy in prostate cancer: diffusion-weighted MR imaging. (abstr) Society of Gastrointestinal Radiologists Abdominal Radiology Course. Maui, HI: Society of Gastrointestinal Radiologists, 2009:51
13. Park BK, Lee HM, Kim CK, Choi HY, Park JW. Lesion localization in patients with a previous negative transrectal ultrasound biopsy and persistently elevated prostate specific antigen level using diffusion-weighted imaging at three Tesla before rebiopsy. Invest Radiol 2008; 43:789-793
14. Hambrock T, Futterer JJ, Huisman HJ, et al. Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility. Invest Radiol 2008; 43:686-694
15. Somford DM, Futterer JJ, Hambrock T, Barentsz JO. Diffusion and perfusion MR imaging of the prostate. Magn Reson Imaging Clin N Am 2008; 16:685-695 [ix]
16. Le Bihan D. Diffusion/perfusion MR imaging of the brain: from structure to function. Radiology 1990; 177:328-329 (Pubitemid 20374842)
17. Schaefer PW, Grant PE, Gonzalez RG. Diffusion-weighted MR imaging of the brain. Radiology 2000; 217:331-345
18. Sugahara T, Korogi Y, Kochi M, et al. Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 1999; 9:53-60 (Pubitemid 29068231)
19. Gauvain KM, McKinstry RC, Mukherjee P, et al. Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging. AJR 2001; 177:449-454 (Pubitemid 32660511)
20. Lang P, Wendland MF, Saeed M, et al. Osteogenic sarcoma: noninvasive in vivo assessment of tumor necrosis with diffusion-weighted MR imaging. Radiology 1998; 206:227-235 (Pubitemid 28063011)
21. Kim CK, Park BK, Han JJ, Kang TW, Lee HM. Diffusion-weighted imaging of the prostate at 3 T for differentiation of malignant and benign tissue in transition and peripheral zones: preliminary results. J Comput Assist Tomogr 2007; 31:449-454
22. Tamada T, Sone T, Jo Y, et al. Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade. J Magn Reson Imaging 2008; 28:720-726
23. Gurses B, Kabakci N, Kovanlikaya A, et al. Diffusion tensor imaging of the normal prostate at 3 Tesla. Eur Radiol 2008; 18:716-721 (Pubitemid 351447776)
24. Takayama Y, Kishimoto R, Hanaoka S, et al. ADC value and diffusion tensor imaging of prostate cancer: changes in carbon-ion radiotherapy. J Magn Reson Imaging 2008; 27:1331-1335 (Pubitemid 351770686)
25. Lim HK, Kim JK, Kim KA, Cho KS. Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection - a multireader study. Radiology 2009; 250:145-151
26. Helpap B, Egevad L. Correlation of modified Gleason grading with pT stage of prostatic carcinoma after radical prostatectomy. Anal Quant Cytol Histol 2008; 30:1-7 (Pubitemid 351312094)
27. Chelsky MJ, Schnall MD, Seidmon EJ, Pollack HM. Use of endorectal surface coil magnetic resonance imaging for local staging of prostate cancer. J Urol 1993; 150:391-395
28. Harris RD, Schned AR, Heaney JA. Staging of prostate cancer with endorectal MR imaging: lessons from a learning curve. RadioGraphics 1995; 15:813-829; discussion, 829-832
29. Ikonen S, Karkkainen P, Kivisaari L, et al. Endorectal magnetic resonance imaging of prostatic cancer: comparison between fat-suppressed T2-weighted fast spin echo and three-dimensional dual-echo, steady-state sequences. Eur Radiol 2001; 11:236-241 (Pubitemid 32755442)
30. Presti JC Jr, Hricak H, Narayan PA, Shinohara K, White S, Carroll PR. Local staging of prostatic carcinoma: comparison of transrectal sonography and endorectal MR imaging. AJR 1996; 166:103-108 (Pubitemid 26010231)
31. Ramsden AR, Chodak G. An analysis of risk factors for biochemical progression in patients with seminal vesicle invasion: validation of Kattan's nomogram in a pathological subgroup. BJU Int 2004; 93:961-964 (Pubitemid 38758613)
32. Qayyum A, Coakley FV, Lu Y, et al. Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging. AJR 2004; 183:1079-1083 (Pubitemid 44185100)
33. White S, Hricak H, Forstner R, et al. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology 1995; 195:385-390
34. Singh AK, Krieger A, Lattouf JB, et al. Patient selection determines the prostate cancer yield of dynamic contrast-enhanced magnetic resonance imaging-guided transrectal biopsies in a closed 3-Tesla scanner. BJU Int 2008; 101:181-185 (Pubitemid 350294043)
35. Kumar V, Jagannathan NR, Kumar R, et al. Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional (1)H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4-10 ng/mL. NMR Biomed 2007; 20:11-20 (Pubitemid 46332437)
36. Hricak H, Choyke PL, Eberhardt SC, Leibel SA, Scardino PT. Imaging prostate cancer: a multidisciplinary perspective. Radiology 2007; 243:28-53 (Pubitemid 46579693)
37. Pucar D, Shukla-Dave A, Hricak H, et al. Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy - initial experience. Radiology 2005; 236:545-553 (Pubitemid 41023438)
38. Huber P, Debus J, Jenne J, et al. Therapeutic ultrasound in tumor therapy: principles, applications and new developments [in German]. Radiologe 1996; 36:64-71
39. Kirkham AP, Emberton M, Hoh IM, Illing RO, Freeman AA, Allen C. MR imaging of prostate after treatment with high-intensity focused ultrasound. Radiology 2008; 246:833-844
40. Hamstra DA, Rehemtulla A, Ross BD. Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology. J Clin Oncol 2007; 25:4104-4109 (Pubitemid 47495868)
41. Moffat BA, Chenevert TL, Lawrence TS, et al. Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci USA 2005; 102:5524-5529
42. 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma. J Vasc Interv Radiol 2007; 18:49-56
43. DeVries AF, Kremser C, Hein PA, et al. Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int J Radiat Oncol Biol Phys 2003; 56:958-965 (Pubitemid 36794026)
44. Byun WM, Shin SO, Chang Y, Lee SJ, Finsterbusch J, Frahm J. Diffusion-weighted MR imaging of metastatic disease of the spine: assessment of response to therapy. AJNR 2002; 23:906-912 (Pubitemid 34663429)
45. Padhani AR, Liu G, Koh DM, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009; 11:102-125
46. Mulkern RV, Barnes AS, Haker SJ, et al. Biexponential characterization of prostate tissue water diffusion decay curves over an extended b-factor range. Magn Reson Imaging 2006; 24:563-568
47. Shinmoto H, Oshio K, Tanimoto A, et al. Biexponential apparent diffusion coefficients in prostate cancer. Magn Reson Imaging 2009; 27:355-359
48. Kitajima K, Kaji Y, Kuroda K, Sugimura K. High b-value diffusion-weighted imaging in normal and malignant peripheral zone tissue of the prostate: effect of signal-to-noise ratio. Magn Reson Med Sci 2008; 7:93-99
49. Niendorf T, Dijkhuizen RM, Norris DG, van Lookeren Campagne M, Nicolay K. Biexponential diffusion attenuation in various states of brain tissue: implications for diffusion-weighted imaging. Magn Reson Med 1996; 36:847-857 (Pubitemid 26396812)
50. Maier SE, Bogner P, Bajzik G, et al. Normal brain and brain tumor: multicomponent apparent diffusion coefficient line scan imaging. Radiology 2001; 219:842-849 (Pubitemid 32476283)
51. Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 2004; 22:275-282
52. Kwee TC, Takahara T, Ochiai R, Nievelstein RA, Luijten PR. Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol 2008; 18:1937-1952
53. Murtz P, Krautmacher C, Traber F, Gieseke J, Schild HH, Willinek WA. Diffusion-weighted whole-body MR imaging with background body signal suppression: a feasibility study at 3.0 Tesla. Eur Radiol 2007; 17:3031-3037 (Pubitemid 350142327)
54. Issa B. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging. J Magn Reson Imaging 2002; 16:196-200
55. Chan I, Wells W 3rd, Mulkern RV, et al. Detection of prostate cancer by integration of line-scan diffusion, T2-mapping and T2-weighted magnetic resonance imaging; a multichannel statistical classifier. Med Phys 2003; 30:2390-2398
56. Hosseinzadeh K, Schwarz SD. Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. J Magn Reson Imaging 2004; 20:654-661 (Pubitemid 39313742)
57. Sato C, Naganawa S, Nakamura T, et al. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging 2005; 21:258-262 (Pubitemid 40280120)
58. Tanimoto A, Nakashima J, Kohno H, Shinmoto H, Kuribayashi S. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging 2007; 25:146-152 (Pubitemid 46095209)